ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
A Phase II, Open-Label Study of the Efficacy and Safety of Imiquimod in the Treatment of Superficial and Mixed Infantile Hemangioma
Pediatric Dermatology
◽
10.1111/j.1525-1470.2008.00857.x
◽
2009
◽
Vol 26
(2)
◽
pp. 203-212
◽
Cited By ~ 46
Author(s):
Catherine C. McCuaig
◽
Josée Dubois
◽
Julie Powell
◽
Claude Belleville
◽
Michèle David
◽
...
Keyword(s):
Phase Ii
◽
Infantile Hemangioma
◽
Efficacy And Safety
◽
Open Label
◽
Open Label Study
◽
Label Study
Download Full-text
Related Documents
Cited By
References
A Phase II, Open-Label Study of the Efficacy and Safety of Imiquimod in the Treatment of Superficial and Mixed Infantile Hemangioma
Yearbook of Dermatology and Dermatologic Surgery
◽
10.1016/s0093-3619(09)79475-4
◽
2010
◽
Vol 2010
◽
pp. 277-279
Author(s):
G.K. Kim
◽
J.Q. Del Rosso
Keyword(s):
Phase Ii
◽
Infantile Hemangioma
◽
Efficacy And Safety
◽
Open Label
◽
Open Label Study
◽
Label Study
Download Full-text
1153TiP A phase II, open label study to investigate the efficacy and safety of domatinostat in combination with avelumab in patients with advanced unresectable/metastatic Merkel cell carcinoma progressing on anti-PD-(L)1 antibody therapy: The MERKLIN 2 study
Annals of Oncology
◽
10.1016/j.annonc.2020.08.1276
◽
2020
◽
Vol 31
◽
pp. S767-S768
Author(s):
A.C.J. van Akkooi
◽
P.A. Ascierto
◽
J.C. Becker
◽
P. Nathan
◽
P. Nghiem
◽
...
Keyword(s):
Cell Carcinoma
◽
Merkel Cell Carcinoma
◽
Phase Ii
◽
Antibody Therapy
◽
Merkel Cell
◽
Efficacy And Safety
◽
Open Label
◽
Open Label Study
◽
Label Study
Download Full-text
Phase II Open-Label Study to Assess Efficacy and Safety of Lenalidomide in Combination with Cetuximab in KRAS-Mutant Metastatic Colorectal Cancer
PLoS ONE
◽
10.1371/journal.pone.0062264
◽
2013
◽
Vol 8
(11)
◽
pp. e62264
◽
Cited By ~ 17
Author(s):
Salvatore Siena
◽
Eric Van Cutsem
◽
Mingyu Li
◽
Ulf Jungnelius
◽
Alfredo Romano
◽
...
Keyword(s):
Colorectal Cancer
◽
Metastatic Colorectal Cancer
◽
Phase Ii
◽
Efficacy And Safety
◽
Open Label
◽
Open Label Study
◽
Label Study
Download Full-text
Efficacy and safety of olaparib monotherapy in a subgroup of patients with a germline BRCA1/2 mutation and advanced ovarian cancer from a Phase II open-label study.
Journal of Clinical Oncology
◽
10.1200/jco.2015.33.15_suppl.5529
◽
2015
◽
Vol 33
(15_suppl)
◽
pp. 5529-5529
◽
Cited By ~ 1
Author(s):
Susan M. Domchek
◽
Ronnie Shapira-Frommer
◽
Rita K. Schmutzler
◽
M. William Audeh
◽
Michael Friedlander
◽
...
Keyword(s):
Ovarian Cancer
◽
Phase Ii
◽
Advanced Ovarian Cancer
◽
Efficacy And Safety
◽
Open Label
◽
Open Label Study
◽
Label Study
Download Full-text
Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study
International Journal of Infectious Diseases
◽
10.1016/j.ijid.2021.03.015
◽
2021
◽
Vol 105
◽
pp. 516-521
Author(s):
Anuja Pandit
◽
Nirav Bhalani
◽
B.L. Shashi Bhushan
◽
Parshottam Koradia
◽
Shweta Gargiya
◽
...
Keyword(s):
Phase Ii
◽
Pegylated Interferon
◽
Interferon Alfa
◽
Efficacy And Safety
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Randomized Controlled
◽
Pegylated Interferon Alfa
Download Full-text
Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open‐label study
British Journal of Haematology
◽
10.1111/bjh.17190
◽
2020
◽
Vol 192
(1)
◽
pp. 190-199
Author(s):
Jun Ho Jang
◽
Yoshiaki Tomiyama
◽
Koji Miyazaki
◽
Koji Nagafuji
◽
Kensuke Usuki
◽
...
Keyword(s):
Aplastic Anaemia
◽
Phase Ii
◽
Efficacy And Safety
◽
Open Label
◽
Open Label Study
◽
Label Study
Download Full-text
Corrigendum to “Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study” [International Journal of Infectious Diseases, Volume 105, April 2021, Pages 516-521]
International Journal of Infectious Diseases
◽
10.1016/j.ijid.2021.06.030
◽
2021
◽
Author(s):
Anuja Pandit
◽
Nirav Bhalani
◽
B.L. Shashi Bhushan
◽
Parshottam Koradia
◽
Shweta Gargiya
◽
...
Keyword(s):
Infectious Diseases
◽
Phase Ii
◽
Pegylated Interferon
◽
Interferon Alfa
◽
Efficacy And Safety
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Randomized Controlled
◽
Pegylated Interferon Alfa
Download Full-text
Faculty of 1000 evaluation for Survival data from a phase II, open-label study of pazopanib or lapatinib monotherapy in patients with advanced and recurrent cervical cancer.
F1000 - Post-publication peer review of the biomedical literature
◽
10.3410/f.717998895.793474496
◽
2013
◽
Author(s):
David Kushner
Keyword(s):
Cervical Cancer
◽
Phase Ii
◽
Survival Data
◽
Open Label
◽
Recurrent Cervical Cancer
◽
Open Label Study
◽
Label Study
Download Full-text
A Pharmacological Batch of Mongersen that Downregulates Smad7 is Effective as Induction Therapy in Active Crohn’s Disease: A Phase II, Open-Label Study
BioDrugs
◽
10.1007/s40259-021-00482-x
◽
2021
◽
Vol 35
(3)
◽
pp. 325-336
Author(s):
Irene Marafini
◽
Carmine Stolfi
◽
Edoardo Troncone
◽
Elisabetta Lolli
◽
Sara Onali
◽
...
Keyword(s):
Crohn’S Disease
◽
Crohn's Disease
◽
Phase Ii
◽
Induction Therapy
◽
Open Label
◽
Open Label Study
◽
Label Study
Download Full-text
THE EFFICACY AND SAFETY OF ALIROCUMAB IN CHILDREN AND ADOLESCENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HOFH): PHASE 3, MULTINATIONAL OPEN-LABEL STUDY
Journal of the American College of Cardiology
◽
10.1016/s0735-1097(21)01800-3
◽
2021
◽
Vol 77
(18)
◽
pp. 441
Author(s):
Eric Bruckert
◽
Sonia Caprio
◽
Albert Wiegman
◽
Min-Ji Charng
◽
Cézar A. Zárate-Morales
◽
...
Keyword(s):
Children And Adolescents
◽
Familial Hypercholesterolemia
◽
Efficacy And Safety
◽
Homozygous Familial Hypercholesterolemia
◽
Open Label
◽
Phase 3
◽
Open Label Study
◽
Label Study
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close